Patterson Companies Stock Intrinsic Value – PATTERSON COMPANIES Reports Q1 FY2024 Earnings with 3.5% Revenue Increase and 27.0% Net Income Growth

☀️Earnings Overview

For the first quarter of FY2024, PATTERSON COMPANIES ($NASDAQ:PDCO) posted total revenue of USD 1576.7 million, an increase of 3.5% compared to the same period last year, and a net income of USD 31.2 million, up 27.0% year-on-year. The earnings results were announced on August 30 2023, for the period ending July 31 2023.

Analysis – Patterson Companies Stock Intrinsic Value

GoodWhale has conducted an analysis of PATTERSON COMPANIES‘s wellbeing and found that the fair value of their stock is around $29.6. This valuation has been calculated using GoodWhale’s proprietary Valuation Line. Currently, PATTERSON COMPANIES is being traded at $30.7, which is a fair price, but is overvalued by 3.7%. This means that investors may be paying a premium for PATTERSON COMPANIES’s stock, suggesting that there is high demand for the company’s shares. However, it’s important to remember that this figure may not be entirely accurate and that investors should carry out their own research before making any decisions. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Patterson Companies. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Patterson Companies. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Patterson Companies. More…

Key Ratios Snapshot

Some of the financial key ratios for Patterson Companies are shown below. More…

Peers

The company’s competitors include PT Soho Global Health Tbk, BioGaia AB, and ForU Holdings Inc.

– PT Soho Global Health Tbk ($IDX:SOHO)

Soho Global Health Tbk is a leading healthcare company in Indonesia with a market cap of 7.04T as of 2022. The company has a strong focus on providing quality healthcare services to the Indonesian people. It has a wide range of products and services including hospitals, clinics, pharmacies, and medical equipment. The company has a strong focus on research and development to bring new and innovative products to the market. The company has a strong financial position with a return on equity of 15.28%.

– BioGaia AB ($LTS:0GTN)

Biogaia AB is a Swedish biotechnology company that develops, manufactures, and markets probiotic products for human and animal health. The company focuses on the development of lactic acid bacteria for the prevention and treatment of gastrointestinal diseases. Its products include Probio-Kid, a probiotic supplement for children; Probio-Stick, a probiotic supplement for adults; and BioGaia Protectis, a probiotic infant formula. Biogaia AB was founded in 1990 and is headquartered in Stockholm, Sweden.

– ForU Holdings Inc ($OTCPK:FORU)

Founded in 2013, U.S.-based ForU Holdings Inc is a provider of solar panel installation services. As of 2022, the company had a market capitalization of $3.61 million and a return on equity of 65.19%. The company’s solar panel installation services are available in the United States, Canada, and the United Kingdom.

Summary

Patterson Companies reported strong financial results for its first quarter of fiscal year 2024. Total revenues of USD 1576.7 million showed a 3.5% year-over-year increase, while net income of USD 31.2 million representing a 27.0% YoY growth. Despite the results, the stock price moved down on the same day.

This could be attributed to investor expectations of higher returns or a larger margin of growth for the company. Investors should consider these results when evaluating Patterson Companies and take into account the overall market conditions to make a more informed decision when deciding whether or not to invest.